Reproducibility-driven discovery and systematic benchmarking reveal a robust cerebrospinal fluid proteomic signature in Alzheimer's disease
By implementing a reproducibility-driven framework across multiple cohorts, this study identifies and validates a robust 11-protein cerebrospinal fluid signature (PPAV11) that demonstrates superior diagnostic accuracy, prognostic capacity, and cross-context stability for Alzheimer's disease compared to previously published biomarkers.